Darunavir
Darunavir is a generic prescription drug used to treat HIV infection by blocking the virus's ability to multiply. It comes as oral tablets in strengths of 75mg, 150mg, 600mg, and 800mg, manufactured by Zydus Lifesciences Limited. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Darunavir is a generic prescription drug used to treat HIV infection by blocking the virus's ability to multiply. It comes as oral tablets in strengths of 75mg, 150mg, 600mg, and 800mg, manufactured by Zydus Lifesciences Limited. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Darunavir",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Darunavir — ANDA 210677 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210677"
}
]
|
| identifier | ANDA210677 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Darunavir |
